Caribou Biosciences (CRBU) Amortizatization of Intangibles (2021 - 2026)

Caribou Biosciences' (CRBU) quarterly Amortizatization of Intangibles came in at $269000.0 in Q1 2026, down 40.49% year-on-year from $452000.0 in Q1 2025, and up 68.12% on a QoQ basis from $160000.0 in Q4 2025.

Caribou Biosciences (CRBU) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Caribou Biosciences (CRBU) has 6 years of Amortizatization of Intangibles data on file, last reported at $269000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 40.49% year-over-year to $269000.0 in Q1 2026; TTM through Mar 2026 was $957000.0, a 73.7% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 75.88% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $269000.0, up from $160000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for CRBU reached as high as $2.4 million in Q3 2023 and fell as low as -$1.6 million in Q4 2023.
  • Historically, Amortizatization of Intangibles has averaged $668058.8 across 5 years, with a median of $452000.0 in 2025.
  • Across the five-year window, Amortizatization of Intangibles soared 1836.54% in 2022 and plunged 279.07% in 2023, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $903000.0 in 2022, then plunged by 279.07% to -$1.6 million in 2023, then soared by 162.96% to $1.0 million in 2024, then sank by 84.28% to $160000.0 in 2025, then jumped by 68.12% to $269000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $269000.0 in Q1 2026, $160000.0 in Q4 2025, and $235000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Caribou Biosciences 152.90 Mn 35.27 Mn - 269,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 269,000.00
Mar 31, 2026 269,000.00
Dec 31, 2025 160,000.00
Dec 31, 2025 160,000.00
Sep 30, 2025 235,000.00
Sep 30, 2025 235,000.00
Jun 30, 2025 293,000.00
Jun 30, 2025 293,000.00
Mar 31, 2025 452,000.00
Mar 31, 2025 452,000.00
Dec 31, 2024 1.02 Mn
Dec 31, 2024 1.02 Mn
Sep 30, 2024 1.22 Mn
Sep 30, 2024 1.22 Mn
Jun 30, 2024 946,000.00
Jun 30, 2024 946,000.00
Mar 31, 2024 1.54 Mn
Mar 31, 2024 1.54 Mn
Dec 31, 2023 -1.62 Mn
Dec 31, 2023 -1.62 Mn